Sale of 17,800 shares at $7.09 per share.
Reporting Person DeGolyer Donald W · Transaction Code S
Traded Oct 7, 2026 · Disclosed Oct 7, 2026
Source: SEC Form 4 · 0001583098-26-000008 · filed 2026-10-07 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Emergent BioSolutions Inc. (EBS)." Disclosed 2026-10-07. https://desqlong.com/cards/0001583098-26-000008-1 (retrieved 2026-10-08).